We studied the potential neuroprotective action of nicergoline in immortali
zed hypothalamic GT1-7 cells exposed to agents which deplete levels of redu
ced glutathione, thus causing oxidative stress and cell death. Treatment wi
th diethylmaleate (1 mM), buthionine sulfoximine (500 mu M) or menadione (1
0-50 mu M) caused diffuse GT1-7 cell degeneration, as assessed by using eit
her the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
cytotoxicity assay or the fluorescent dyes fluorescein diacetate and propid
ium iodide. Pre- and/or co-exposure of the cells to nicergoline significant
ly prevented diethylmaleate- or buthionine sulfoximine-induced neuronal dea
th, whereas nicergoline was ineffective against menadione-induced toxicity.
This effect was concentration-dependent and was mimicked by the classical
antioxidants idebenone and vitamin E, and did not depend on interference wi
th protein kinase C. Interestingly, the antineurodegenerative activity of n
icergoline and Vitamin E or idebenone was not additive, suggesting that the
se compounds share some intracellular mechanism(s) responsible for their pr
otective effects. In conclusion, the present data indicate that nicergoline
has neuroprotective activity, possibly mediated by the antioxidant activit
y of the molecule, and give support to the potential use of nicergoline in
the prevention and therapy of neurodegenerative diseases. (C) 1999 Elsevier
Science B.V. All rights reserved.